%0 Journal Article
%T HIV感染/AIDS合并结核病的临床研究进展
Progress in Clinical Research of HIV Infection/AIDS Combined with Tuberculosis
%A 陈秋菊
%A 陈晓红
%J Advances in Clinical Medicine
%P 1493-1500
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.132207
%X 世界范围内人获得性免疫缺陷病毒(HIV)感染/获得性免疫缺陷综合征(AIDS)合并结核病(TB)的发病率和检出率不断升高,HIV可诱导机体炎性因子分泌和体细胞免疫功能缺陷的增加,从而增加患者感染结核分枝杆菌(Mycobacterium tuberculosis,MTB)的风险。而感染MTB可上调共受体CCR5和CXCR4的表达,从而促进HIV病毒感染巨噬细胞和T细胞。HIV感染/AIDS合并TB患者的结核症状于免疫功能有关,同时以Gene Xpert MTB/RIF为代表的新型分子生物学技术也具有良好的病原学诊断价值。目前,科学规范的临床治疗、管理仍是HIV感染/AIDS合并TB首选的防控策略。因此,本文对HIV感染/AIDS合并TB的流行病学、发病机制、临床表现及诊治等方面进行综述,以期为HIV感染/AIDS合并TB的临床防控提供一定的参考依据。
The incidence and detection rate of human acquired immunodeficiency virus (HIV) infec-tion/acquired immunodeficiency syndrome (AIDS) combined with tuberculosis (TB) are increasing worldwide. HIV can induce the secretion of inflammatory factors and the increase of somatic im-mune dysfunction. That increases the risk of contracting Mycobacterium tuberculosis (MTB). How-ever, infection with MTB can up-regulate the expression of co-receptors CCR5 and CXCR4, thus pro-moting HIV infection of macrophages and T cells. The tuberculosis symptoms of HIV infection/AIDS patients with TB are related to immune function. Meanwhile, the novel molecular biological tech-nology represented by Gene Xpert MTB/RIF also has good value in etiological diagnosis. At present, scientific and standardized clinical treatment and management are still the preferred prevention and control strategies for HIV infection/AIDS complicated with TB. Therefore, this paper reviews the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of HIV infec-tion/AIDS complicated with TB, in order to provide certain reference for the clinical prevention and control of HIV infection/AIDS complicated with TB.
%K 人获得性免疫缺陷病毒,获得性免疫缺陷综合征,结核病,研究进展
Human Immunodeficiency Virus
%K Acquired Immune Deficiency Syndrome
%K Tuberculosis
%K Research Progress
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=61165